Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Escitalopram oxalate
Drug ID BADD_D00810
Description Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]
Indications and Usage Escitalopram is indicated for both acute and maintenance treatment of major depressive disorder (MDD) and for the acute treatment of generalized anxiety disorder (GAD).[L8513] It is additionally indicated for symptomatic relief of obsessive-compulsive disorder (OCD) in Canada.[L8516]
Marketing Status approved
ATC Code N06AB10
DrugBank ID DB01175
KEGG ID D02567
MeSH ID D000089983
PubChem ID 146571
TTD Drug ID D08RBC
NDC Product Code 82009-036; 58032-0134; 65015-886; 50090-6025; 65862-248; 65862-373; 68071-3265; 68084-618; 70934-060; 71205-792; 0615-8475; 68788-8371; 0904-6427; 68554-0136; 16571-769; 42708-077; 45865-996; 55700-993; 65162-019; 70518-1291; 68001-195; 68001-196; 0615-8477; 82009-037; 0456-2021; 55111-944; 71052-647; 50090-6496; 55154-6893; 63629-2981; 63629-8042; 70518-0791; 82009-035; 45562-1130; 68554-0007; 13668-135; 43063-761; 50090-6023; 65162-021; 71205-193; 71335-9687; 0615-8476; 82982-065; 53104-7565; 70966-0032; 72761-009; 51655-147; 65862-375; 68084-617; 0456-2006; 65372-1116; 65691-0066; 13668-136; 31722-569; 55154-7288; 72789-311; 51686-0011; 64220-109; 65862-411; 50090-1279; 51672-1348; 61919-139; 65862-374; 68001-197; 71205-168; 71335-0685; 0904-6426; 0456-2011; 13668-137; 65162-020; 71205-313; 71335-0658; 65372-1143
UNII 5U85DBW7LO
Synonyms Escitalopram | Escitalopram Oxalate | Lexapro
Chemical Information
Molecular Formula C22H23FN2O5
CAS Registry Number 219861-08-2
SMILES CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nystagmus17.02.02.006; 06.05.02.006--
Oedema14.05.06.010; 08.01.07.006--Not Available
Orthostatic hypotension17.05.01.020; 24.06.03.004--Not Available
Pain in extremity15.03.04.010--
Palpitations02.11.04.012--
Pancreatitis07.18.01.001--
Panic reaction19.06.04.003--Not Available
Paraesthesia23.03.03.094; 17.02.06.005--
Paranoia19.05.01.005--Not Available
Parkinsonism17.01.05.003--Not Available
Persistent foetal circulation24.03.03.004; 18.04.07.001; 03.07.01.002; 02.08.02.001--Not Available
Phlebitis24.12.03.004; 12.02.01.002--
Photosensitivity reaction23.03.09.003--
Pollakiuria20.02.02.007--
Priapism21.03.01.005; 24.04.12.007--Not Available
Prothrombin level decreased13.01.02.010--Not Available
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Rectal haemorrhage24.07.02.018; 07.12.03.001--
Restlessness19.11.02.002; 17.02.05.021--
Rhabdomyolysis15.05.05.002--
Rhinitis22.07.03.006; 11.01.13.004--
Seizure17.12.03.001--
Sinus congestion22.04.06.001--Not Available
Sinus headache22.12.03.022; 17.14.01.002--
Sinusitis22.07.03.007; 11.01.13.005--
Somnolence19.02.05.003; 17.02.04.006--
Stevens-Johnson syndrome10.01.01.045; 23.03.01.007; 12.03.01.014; 11.07.01.005--
Suicidal ideation19.12.01.003--
The 5th Page    First    Pre   5 6 7    Next   Last    Total 7 Pages